DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,161,852 | -78.2% | 4,683 | -76.7% | 0.05% | -64.3% |
| Q4 2022 | $5,340,516 | -68.3% | 20,121 | -69.2% | 0.14% | -71.3% |
| Q3 2022 | $16,862,000 | +384.1% | 65,284 | +375.2% | 0.50% | +269.6% |
| Q2 2022 | $3,483,000 | -89.1% | 13,737 | -87.4% | 0.14% | -87.0% |
| Q1 2022 | $31,869,000 | +14.3% | 108,644 | +28.2% | 1.04% | +15.3% |
| Q4 2021 | $27,874,000 | +89.1% | 84,720 | +74.9% | 0.90% | +126.4% |
| Q3 2021 | $14,744,000 | +104.5% | 48,431 | +49.2% | 0.40% | +148.8% |
| Q4 2020 | $7,209,000 | +974.4% | 32,452 | +755.8% | 0.16% | +344.4% |
| Q2 2020 | $671,000 | -90.4% | 3,792 | -92.2% | 0.04% | -92.6% |
| Q3 2019 | $7,019,000 | -25.5% | 48,596 | -47.9% | 0.48% | +24.1% |
| Q2 2016 | $9,419,000 | +63.8% | 93,260 | +38.2% | 0.39% | +105.3% |
| Q3 2015 | $5,752,000 | +151.1% | 67,499 | +150.1% | 0.19% | +54.5% |
| Q1 2015 | $2,291,000 | +7.4% | 26,986 | -3.9% | 0.12% | +53.8% |
| Q3 2014 | $2,134,000 | – | 28,084 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |